Showing results (1-10 of 1,021) with videos related to
Sort By:
Pageof 103
Bone|March 8, 2016
The effects of proteasome inhibitors on bone remodeling in multiple myelomaMaurizio Zangari, Larry J SuvaCurrent Opinion in Supportive and Palliative Care|July 27, 2010
Bone and paraproteinemiasMaurizio Zangari, Fenghuang Zhan, Guido TricotEuropean Journal of Haematology|May 25, 2012
Low-risk identification in multiple myeloma using a new 14-gene modelTiehua Chen, Tamara Berno, Maurizio ZangariCurrent Pharmaceutical Biotechnology|December 16, 2006
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myelomaMaurizio Zangari, Federica Cavallo, Guido TricotExpert Opinion on Investigational Drugs|November 1, 2005
Immunomodulatory drugs in multiple myelomaMaurizio Zangari, Francesca Elice, Guido TricotThrombosis Research|May 4, 2010
Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impactF Elice, F RodeghieroClinical Lymphoma, Myeloma & Leukemia|May 18, 2011
Low venous thromboembolic risk with bortezomib in multiple myeloma and potential protective effect with thalidomide/lenalidomide-based therapy: review of data from phase 3 trials and studies of novel combination regimensMaurizio Zangari, Louis Fink, Fenghuang Zhan, et al.Seminars in Oncology|January 10, 2003
High-dose therapy and immunomodulatory drugs in multiple myelomaBart Barlogie, John Shaughnessy, Maurizio Zangari, et al.Pageof 103